Literature DB >> 28605283

Interferon-β controls non-tuberculous mycobacterial infection in mice.

Mohd-Nor Norazmi1.   

Abstract

Entities:  

Keywords:  immunosuppression; non-tuberculous mycobacteria; tuberculosis; type I interferon

Mesh：

Substances：

Year:  2017        PMID： 28605283      PMCID： PMC5711353          DOI： 10.1080/21505594.2017.1341035

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  19 in total

1.  Increasing isolation of rapidly growing mycobacteria in a low-incidence setting of environmental mycobacteria, 1994-2015.

Authors:  F Alcaide; M J Peña; D Pérez-Risco; D Camprubi; L Gonzalez-Luquero; M D Grijota-Camino; J Dorca; M Santin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-20       Impact factor: 3.267

2.  cGAS-STING-TBK1-IRF3/7 induced interferon-β contributes to the clearing of non tuberculous mycobacterial infection in mice.

Authors:  Nanthapon Ruangkiattikul; Andreas Nerlich; Ketema Abdissa; Stefan Lienenklaus; Abdulhadi Suwandi; Nina Janze; Kristin Laarmann; Julia Spanier; Ulrich Kalinke; Siegfried Weiss; Ralph Goethe
Journal:  Virulence       Date:  2017-04-19       Impact factor: 5.882

3.  In vitro differentiation of human macrophages with enhanced antimycobacterial activity.

Authors:  Guillaume Vogt; Carl Nathan
Journal:  J Clin Invest       Date:  2011-09-12       Impact factor: 14.808

4.  Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000.

Authors:  C R Horsburgh; J Gettings; L N Alexander; J L Lennox
Journal:  Clin Infect Dis       Date:  2001-10-24       Impact factor: 9.079

5.  Dynamics of immune effector mechanisms during infection with Mycobacterium avium in C57BL/6 mice.

Authors:  Markus Haug; Jane A Awuh; Magnus Steigedal; June Frengen Kojen; Anne Marstad; Ivar S Nordrum; Øyvind Halaas; Trude H Flo
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

Review 6.  Nontuberculous mycobacterial lung disease.

Authors:  David E Griffith
Journal:  Curr Opin Infect Dis       Date:  2010-04       Impact factor: 4.915

7.  Mycobacterium mageritense pulmonary disease in patient with compromised immune system.

Authors:  R Gordon Huth; Barbara A Brown-Elliott; Richard J Wallace
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

8.  CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease.

Authors:  Shunsuke Sakai; Keith D Kauffman; Michelle A Sallin; Arlene H Sharpe; Howard A Young; Vitaly V Ganusov; Daniel L Barber
Journal:  PLoS Pathog       Date:  2016-05-31       Impact factor: 6.823

9.  An association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammation.

Authors:  Paul E Pfeffer; Susan Hopkins; Ian Cropley; David M Lowe; Marc Lipman
Journal:  Respir Res       Date:  2017-05-15

Review 10.  Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis.

Authors:  Kai Ling Chin; Fadhilah Zulkipli Anis; Maria E Sarmiento; Mohd Nor Norazmi; Armando Acosta
Journal:  J Immunol Res       Date:  2017-06-20       Impact factor: 4.818
View more
  1 in total

Review 1.  Interferon-induced GTPases orchestrate host cell-autonomous defence against bacterial pathogens.

Authors:  Heike L Rafeld; Waldemar Kolanus; Ian R van Driel; Elizabeth L Hartland
Journal:  Biochem Soc Trans       Date:  2021-06-30       Impact factor: 5.407
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.